jan 19, 2005 - British-Columbia Trial

Description:

20-year LR (13 vs 39%) and OS (47 vs 37%) favored adjuvant RT
median 11 LN sampled

For patients with high-risk breast cancer treated with modified radical mastectomy, treatment with radiation therapy (schedule of 16 fractions) and adjuvant chemotherapy leads to better survival outcomes than chemotherapy alone, and it is well tolerated, with acceptable long-term toxicity.

Added to timeline:

Date: